Nantahala Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.28M | Hold |
|
|||||
|
2025
Q1 | $3.84M | Buy |
|
|||||
|
2022
Q2 | – | Hold |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $11.1M | Sell |
|
|||||
|
2021
Q3 | $14.3M | Sell |
|
|||||
|
2021
Q2 | $19.6M | Buy |
|
|||||
|
2021
Q1 | $17.4M | Sell |
|
|||||
|
2020
Q4 | $19.7M | Buy |
|
|||||
|
2020
Q3 | $14.4M | Sell |
|
|||||
|
2020
Q2 | $82.9M | Sell |
|
|||||
|
2020
Q1 | $49.7M | Sell |
|
|||||
|
2019
Q4 | $42.6M | Buy |
|
|||||
|
2019
Q3 | $22.7M | Hold |
|
|||||
|
2019
Q2 | $28M | Buy |
|
|||||
|
2019
Q1 | $40.5M | Sell |
|
|||||
|
2018
Q4 | $28M | Buy |
|
|||||
|
2018
Q3 | $41.7M | Buy |
|
|||||
|
2018
Q2 | $45.1M | Buy |
|
|||||
|
2018
Q1 | $32.3M | Buy |
|
|||||
|
2017
Q4 | $28.8M | Buy |
|
|||||
|
2017
Q3 | $26.9M | Sell |
|
|||||
|
2017
Q2 | $30.9M | Sell |
|
|||||
|
2017
Q1 | $21M | Buy |
|
|||||
|
2016
Q4 | $23.2M | Buy |
|
|||||
|
2016
Q3 | $17.3M | Buy |
|
|||||
|
2016
Q2 | $12.6M | Buy |
|
|||||
|
2016
Q1 | $12.1M | Buy |
|
|||||
|
2015
Q4 | $2.86M | Buy |
|